Studying synergism of methyl linked cyclohexyl thiophenes with triazole: Synthesis and their cdk5/p25 inhibition activity
Authors:
- John ThomasJTJohn Thomas
- Vanita KanaseVKVanita Kanase
- Rajendra DigheRDRajendra Dighe
- 1 June 2011
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 46 (6) , 2066-2074
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Thienylhalomethylketones: Irreversible glycogen synthase kinase 3 inhibitors as useful pharmacological toolsBioorganic & Medicinal Chemistry, 2009
- Synthesis and structure–activity relationship of a novel series of heterocyclic sulfonamide γ-secretase inhibitorsBioorganic & Medicinal Chemistry, 2009
- Discovery and SAR of 2-aminothiazole inhibitors of cyclin-dependent kinase 5/p25 as a potential treatment for Alzheimer’s diseaseBioorganic & Medicinal Chemistry Letters, 2004
- Synthesis and biological activity of N-aryl-2-aminothiazoles: potent pan inhibitors of cyclin-dependent kinasesBioorganic & Medicinal Chemistry Letters, 2004
- N-(Cycloalkylamino)acyl-2-aminothiazole Inhibitors of Cyclin-Dependent Kinase 2. N-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4- piperidinecarboxamide (BMS-387032), a Highly Efficacious and Selective Antitumor AgentJournal of Medicinal Chemistry, 2004
- Discovery of Aminothiazole Inhibitors of Cyclin-Dependent Kinase 2: Synthesis, X-ray Crystallographic Analysis, and Biological ActivitiesJournal of Medicinal Chemistry, 2002
- Tau Protein Phosphorylation as a Therapeutic Target in Alzheimers DiseaseCurrent Topics in Medicinal Chemistry, 2002
- Cdk5 as a Drug Target for the Treatment of Alzheimer's DiseaseJournal of Molecular Neuroscience, 2002
- A decade of CDK5Nature Reviews Molecular Cell Biology, 2001
- Evidence for cdk5 as a Major Activity Phosphorylating Tau Protein in Porcine Brain Extract1The Journal of Biochemistry, 1995